Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11692012 Human cytomegalovirus comprising exogenous antigens
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
March 26, 2021
0
Date of Patent
July 4, 2023
0
Patent Application Number
17214598
0
Patent Citations
US Patent 9541553 CMV glycoproteins and recombinant vectors
0
US Patent 9783823 Cytomegalovirus vectors enabling control of T cell targeting
0
US Patent 9862972 CMV glycoproteins and recombinant vectors
0
US Patent 9982241 Recombinant HCMV and RHCMV vectors and uses thereof
0
US Patent 10101329 CMV glycoproteins and recombinant vectors
0
US Patent 10167321 Cytomegalovirus antigens and uses thereof
0
US Patent 10316334 Cytomegalovirus vectors enabling control of T cell targeting
0
US Patent 10428118 Human cytomegalovirus comprising exogenous antigens
0
US Patent 10532099 Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules
0
US Patent 10760097 CMV glycoproteins and recombinant vectors
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11692012
0
Patent Primary Examiner
Rachel B Gill
0
CPC Code
A61K 39/245
0
A61K 35/763
0
A61K 38/162
0
A61K 2039/525
0
A61K 2039/5256
0
A61K 2039/6075
0
C12N 15/86
0
C12N 7/00
0
C12N 2710/00011
0
C12N 2710/16111
0
•••
Find more entities like US Patent 11692012 Human cytomegalovirus comprising exogenous antigens
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE